MetrionAIIntelligence

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Merrimack Pharmaceuticals, Inc.

MACK

HealthcareNASDAQUS

$15.145

+$0.015 (+0.10%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

MACK

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 15.13H 15.13L 15.13C 15.13Date May 28

MACK

SMA 20 SMA 50 Vol 0EEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$223.97M

Volume?922.50K

Avg Volume?195.54K

52w Range$11.53 - $15.89

Beta?1.42

Price Performance

0.0%

$15.13 to $15.13

YTD

0.0%

$15.13 to $15.13

0.0%

$15.13 to $15.13

+21.5%

$12.45 to $15.13

+134.9%

$6.44 to $15.13

10Y

-72.6%

$55.15 to $15.13

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOGary L. Crocker

IndustryBiotechnology

Employees0

IPO Date2012-03-29

CurrencyUSD

Websitewww.merrimack.com

Related stocks

Check out other names from the same Biotechnology industry as MACK.

CATB-

Catabasis Pharmaceuticals, Inc.

CARGO Therapeutics, Inc. Common Stock

4.47USD

0.00%

INXB-

Inhibrx Biosciences, Inc.

Spectrum Pharmaceuticals, Inc.

1.03USD

-0.49%

TCRT-

Alaunos Therapeutics, Inc.

2.28USD

-6.56%

THRD-

Third Harmonic Bio, Inc.

Zevra Therapeutics, Inc.

10.61USD

-5.01%